P2.01-032 A Randomized Phase Ii Trial of Selumetinib + Platinum-pemetrexed (Pem-c) in Kras Wildtype (Wt)/Unknown NSCLC: CCTG Ind219 von Bradbury, P., Melosky, B., Tu, D., Nicholas, G., Wheatley-Price, P., Laurie, S., Goss, G., Florescu, M., Basappa, N., Reiman, A., Tan, A., Hao, D., Rotherstein, J., Leighl, N., Goffin, J., Kollmannsberger, C., Kaurah, P., Brown-Walker, P., Seymour, L.

Volltext